Comparison of clinical outcomes of different erythropoietin usage strategies.

Arslan, Murat; Evrensel, Turkkan; Kurt, Ender; Demiray, Mutlu; Gonullu, Guzin; Kanat, Ozkan; Manavoglu, Osman

Arslan, Murat; Evrensel, Turkkan; Kurt, Ender; Demiray, Mutlu; Gonullu, Guzin; Kanat, Ozkan; Manavoglu, Osman.

Affiliation

Arslan M; Uludag University Faculty of Medicine, Department of Medical Oncology, Bursa, Turkey. marslan@uludag.edu.tr

Tumori ; 90(4): 394-8, 2004.

Article in En | MEDLINE | ID: mdl-15510982

Subject(s)

Anemia, Hypochromic/drug therapy; Erythropoietin/administration & dosage; Hematinics/administration & dosage; Neoplasms/drug therapy; Platinum Compounds/adverse effects; Adult; Aged; Anemia, Hypochromic/blood; Anemia, Hypochromic/chemically induced; Drug Administration Schedule; Female; Hemoglobins/metabolism; Humans; Male; Middle Aged; Neoplasms/blood; Platinum Compounds/administration & dosage; Recombinant Proteins; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Erythropoietin / Platinum Compounds / Hematinics / Anemia, Hypochromic / Neoplasms Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Tumori Year: 2004 Document type: Article Affiliation country: Turkey Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links